The multi-manager pod shops (Millennium, Citadel, Point72, Balyasny) — seen through the only window a price feed has.
Bind is a member of the Blaque Baux family. The core repo is the engine and blueprint — a governed, systematic platform (Julia) with a venue-agnostic execution controller and a Layer-3 live-money safety gate. Bind points that engine at the rest of the hedge-fund landscape and inherits the governance wholesale.
Not investment advice. Educational/research software. Nothing here is validated. See LICENSE.
git clone --recursive https://github.com/blaquebaux/bind.git
julia --project=engine -e 'using Pkg; Pkg.instantiate()'# one-time engine setupThe multi-strategy pod shops — Millennium, Citadel, Point72, Balyasny, ExodusPoint — are the dominant force in modern hedge funds: dozens of tightly-risk-managed, market-neutral portfolio managers, netted to a low-vol, low-beta, steadily-compounding book, amplified by heavy leverage. Their pitch is uncorrelated, all-weather, ~10-15% with single-digit vol. The catch for a research sleeve: their actual returns are private — no NAV, no ticker, closed to new capital.
So Bind studies the pod-shop style through the only price-testable window: the liquid
hedge-fund-replication ETFs — QAI (multi-strategy), MNA (merger arbitrage), BTAL (anti-beta /
short-market factor), DBMF (managed-futures replication), RLY (real return). The honest question:
do these deliver the uncorrelated, steady profile the pod shops sell, or are they watered-down beta
that mostly proves the real edge — leverage, execution, talent, and access — is not replicable off
the shelf?
- The liquid-alt profile. Characterize QAI/MNA/BTAL/DBMF/RLY: Sharpe, vol, beta and correlation to SPY. Are they genuinely low-beta and uncorrelated, or defensive-equity in disguise?
- The one that's real: BTAL/DBMF. Anti-beta and managed-futures are the two liquid alts with genuinely negative/zero equity beta — test whether they're the tradeable residue of the pod-shop "diversifier" claim (and whether they pair with Bleed).
- The gap, stated. The pod shops' real returns (leverage × many uncorrelated PMs) are private and unreplicable; document what the liquid alts can't stand in for.
Full detail in research/README.md. The scorecard (Alpaca SIP, 2016–2026):
| # | Question | Verdict |
|---|---|---|
| 1 | Style, or watered-down beta? | |
| 2 | Are BTAL/DBMF real diversifiers? | ✅ yes — BTAL +1.33% on worst market days; DBMF ~0-beta, SPY+15% DBMF lifts Sharpe +0.86→+0.92 — but they are anti-beta + managed-futures = the family's Bleed + trend |
| 3 | Does the replication book match the pods? | ❌ +3.5% CAGR — hits the low vol, misses the return (not 10-15%); the real pod-shop edge (leverage × dozens of PMs × execution) is private & unreplicable |
The synthesis: Bind maps the investable hedge-fund landscape and honestly finds nothing to add that the family doesn't already own. The liquid replicators capture the low-vol style but not the edge: they return low single digits, not the pod shops' 10-15%. The only genuinely uncorrelated, buyable slices — DBMF (managed futures, zero beta, +7.9%) and BTAL (anti-beta crisis hedge, up on the worst days but bleeding standalone) — improve an equity book, but they are exactly what Bleed (tail hedge) and the family's trend sleeves already deliver. The real multi-manager return comes from ~4-6× leverage on dozens of genuinely uncorrelated PM books plus elite execution and closed access — none of it purchasable off the shelf. A diagnostic: the landscape holds nothing to buy that Blaque Baux isn't already carrying, and nothing you can buy that reproduces a Citadel.
Research: first pass complete — a diagnostic null. The investable hedge-fund style is watered-down beta; the real pod-shop edge is private and unreplicable; the only useful residue (anti-beta + managed-futures crisis hedges) is already in the family via Bleed and trend. Nothing to add. No live driver; nothing validated to the spine's bar.
Blaque Baux is a quantitative research initiative and a subsidiary of Carter Warrens. BlaqueBaux.com is the home for the work; the code lives here on GitHub — open to study, test, and build bespoke strategies on top of.
Anyone can point an AI at a market. The edge is understanding what the data actually says — and turning it into something you can act on. We test relentlessly and put most of it on the record as rejected, with the reason; what survives is built, governed, and validated before it is ever called real. That combination — honest research, reproducible evidence, and execution you can trust — is why Carter Warrens leads on strategy and implementation, not merely uses the tools everyone now has.
This repo is one sleeve of the Blaque Baux family — a single governed engine steered in many directions. The core repo is the base/blueprint and holds the full family roster.
engine/ the Blaque Baux platform (git submodule -> blaquebaux/base)
research/ three sketches (liquid-alt profile, real diversifiers, replication-vs-pods gap) + scorecard
live/ governed live drivers (once a sleeve graduates to paper A/B)
MIT. (c) 2026 Carter Warrens.